Overkamp T - Search Results

1

Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.

Schoewel V, Marg A, Kunz S, Overkamp T, Carrazedo RS, Zacharias U, Daniel PT, Spuler S. Schoewel V, et al. Among authors: overkamp t. PLoS One. 2012;7(11):e49603. doi: 10.1371/journal.pone.0049603. Epub 2012 Nov 20. PLoS One. 2012. PMID: 23185377 Free PMC article.

2

2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib.

Gohlke BO, Overkamp T, Richter A, Richter A, Daniel PT, Gillissen B, Preissner R. Gohlke BO, et al. Among authors: overkamp t. BMC Bioinformatics. 2015 Sep 24;16:308. doi: 10.1186/s12859-015-0730-x. BMC Bioinformatics. 2015. PMID: 26403354 Free PMC article.

3

p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.

Müer A, Overkamp T, Gillissen B, Richter A, Pretzsch T, Milojkovic A, Dörken B, Daniel PT, Hemmati P. Müer A, et al. Among authors: overkamp t. J Biol Chem. 2012 May 18;287(21):17343-17352. doi: 10.1074/jbc.M111.314898. Epub 2012 Feb 21. J Biol Chem. 2012. PMID: 22354970 Free PMC article.

4

p14ARF induces apoptosis via an entirely caspase-3-dependent mitochondrial amplification loop.

Milojkovic A, Hemmati PG, Müer A, Overkamp T, Chumduri C, Jänicke RU, Gillissen B, Daniel PT. Milojkovic A, et al. Among authors: overkamp t. Int J Cancer. 2013 Dec 1;133(11):2551-62. doi: 10.1002/ijc.28279. Epub 2013 Aug 1. Int J Cancer. 2013. PMID: 23686572

5

Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.

Chumduri C, Gillissen B, Richter A, Richter A, Milojkovic A, Overkamp T, Müller A, Pott C, Daniel PT. Chumduri C, et al. Among authors: overkamp t. J Mol Med (Berl). 2015 May;93(5):559-72. doi: 10.1007/s00109-014-1242-2. Epub 2014 Dec 30. J Mol Med (Berl). 2015. PMID: 25548804

6

Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.

Hemmati PG, Müer A, Gillissen B, Overkamp T, Milojkovic A, Wendt J, Dörken B, Daniel PT. Hemmati PG, et al. Among authors: overkamp t. J Mol Med (Berl). 2010 Jun;88(6):609-22. doi: 10.1007/s00109-010-0606-5. Epub 2010 Apr 25. J Mol Med (Berl). 2010. PMID: 20419447

7

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

Gillissen B, Wendt J, Richter A, Richter A, Müer A, Overkamp T, Gebhardt N, Preissner R, Belka C, Dörken B, Daniel PT. Gillissen B, et al. Among authors: overkamp t. J Cell Biol. 2010 Mar 22;188(6):851-62. doi: 10.1083/jcb.200912070. J Cell Biol. 2010. PMID: 20308427 Free PMC article.

8

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.

Gillissen B, Richter A, Richter A, Overkamp T, Essmann F, Hemmati PG, Preissner R, Belka C, Daniel PT. Gillissen B, et al. Among authors: overkamp t. Cell Death Dis. 2013 May 23;4(5):e643. doi: 10.1038/cddis.2013.67. Cell Death Dis. 2013. PMID: 23703388 Free PMC article.

9

Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level.

Graupner V, Alexander E, Overkamp T, Rothfuss O, De Laurenzi V, Gillissen BF, Daniel PT, Schulze-Osthoff K, Essmann F. Graupner V, et al. Among authors: overkamp t. Cell Death Differ. 2011 Jul;18(7):1130-9. doi: 10.1038/cdd.2010.179. Epub 2011 Jan 14. Cell Death Differ. 2011. PMID: 21233848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters